tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

PEPG Stock Latest News

PepGen Inc. Announces Clinical Hold in the U.S. on IND Application to Initiate a Phase 1 Study of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
Press ReleasesPepGen Inc. Announces Clinical Hold in the U.S. on IND Application to Initiate a Phase 1 Study of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
7d ago
PEPG
PepGen Reports First Quarter 2023 Financial Results and Recent Corporate Developments
Press ReleasesPepGen Reports First Quarter 2023 Financial Results and Recent Corporate Developments
26d ago
PEPG
PepGen Announces Upcoming Data Presentations at the 2023 American Academy of Neurology Annual Meeting
Press ReleasesPepGen Announces Upcoming Data Presentations at the 2023 American Academy of Neurology Annual Meeting
2M ago
PEPG
PepGen to Participate in the 22nd Annual Needham Virtual Healthcare Conference
Press ReleasesPepGen to Participate in the 22nd Annual Needham Virtual Healthcare Conference
2M ago
PEPG
PepGen price target raised to $22 from $17 at Wedbush
The FlyPepGen price target raised to $22 from $17 at Wedbush
2M ago
PEPG
PepGen Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Developments
Press ReleasesPepGen Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Developments
2M ago
PEPG
PepGen to hold trials to assess safety and efficacy of repeated PGN-EDO51 doses
The FlyPepGen to hold trials to assess safety and efficacy of repeated PGN-EDO51 doses
3M ago
PEPG
PepGen Presents Clinical and Nonclinical Data at the 2023 Annual Muscular Dystrophy Association Clinical and Scientific Conference
Press ReleasesPepGen Presents Clinical and Nonclinical Data at the 2023 Annual Muscular Dystrophy Association Clinical and Scientific Conference
3M ago
PEPG
PepGen to Participate in the Stifel 2023 CNS Days Conference
Press ReleasesPepGen to Participate in the Stifel 2023 CNS Days Conference
3M ago
PEPG
PepGen Announces Upcoming Data Presentations at the 2023 Annual Muscle Dystrophy Association Clinical and Scientific Conference
Press ReleasesPepGen Announces Upcoming Data Presentations at the 2023 Annual Muscle Dystrophy Association Clinical and Scientific Conference
3M ago
PEPG
PepGen to Participate in the SVB Securities Global Biopharma Conference
Press ReleasesPepGen to Participate in the SVB Securities Global Biopharma Conference
4M ago
PEPG
PepGen initiated with a Buy at H.C. Wainwright
The FlyPepGen initiated with a Buy at H.C. Wainwright
6M ago
PEPG
PepGen announces new preclinical data on progression of PGN-EDODM1
The FlyPepGen announces new preclinical data on progression of PGN-EDODM1
6M ago
PEPG
PepGen Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
Press ReleasesPepGen Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
7M ago
PEPG
PepGen Presents Data from its Duchenne Muscular Dystrophy Program at World Muscle Society Congress
Press ReleasesPepGen Presents Data from its Duchenne Muscular Dystrophy Program at World Muscle Society Congress
8M ago
PEPG
PepGen (NASDAQ:PEPG) Rises on Promising Phase 1 DMD Trial Data
Market NewsPepGen (NASDAQ:PEPG) Rises on Promising Phase 1 DMD Trial Data
8M ago
PEPG
PepGen Reports Positive Data from Phase 1 Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
Press ReleasesPepGen Reports Positive Data from Phase 1 Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
8M ago
PEPG
3 IPO Stocks to Watch in September
Stock Analysis & Ideas3 IPO Stocks to Watch in September
9M ago
HNVR
PEPG
PepGen Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
Press ReleasesPepGen Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
10M ago
PEPG
PepGen Appoints Caroline Godfrey, Ph.D. to the Company’s Scientific Advisory Board
Press ReleasesPepGen Appoints Caroline Godfrey, Ph.D. to the Company’s Scientific Advisory Board
11M ago
PEPG
PepGen Reports First Quarter 2022 Financial Results and Recent Corporate Developments
Press ReleasesPepGen Reports First Quarter 2022 Financial Results and Recent Corporate Developments
12M ago
PEPG